Gw Pharmaceuticals Plc Stock Total Debt
GW Pharmaceuticals Plc fundamentals help investors to digest information that contributes to GW Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of GWPRF OTC Stock. The fundamental analysis module provides a way to measure GW Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GW Pharmaceuticals otc stock.
GWPRF |
GW Pharmaceuticals Plc OTC Stock Total Debt Analysis
GW Pharmaceuticals' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current GW Pharmaceuticals Total Debt | 42.5 M |
Most of GW Pharmaceuticals' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GW Pharmaceuticals Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, GW Pharmaceuticals Plc has a Total Debt of 42.5 M. This is much higher than that of the sector and significantly higher than that of the Total Debt industry. The total debt for all United States stocks is notably lower than that of the firm.
GWPRF Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GW Pharmaceuticals' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of GW Pharmaceuticals could also be used in its relative valuation, which is a method of valuing GW Pharmaceuticals by comparing valuation metrics of similar companies.GW Pharmaceuticals is currently under evaluation in total debt category among related companies.
GWPRF Fundamentals
| Return On Equity | -9.62 | |||
| Return On Asset | -4.58 | |||
| Profit Margin | (12.49) % | |||
| Operating Margin | (11.73) % | |||
| Current Valuation | 120.65 M | |||
| Shares Outstanding | 378.54 M | |||
| Shares Owned By Insiders | 1.99 % | |||
| Shares Owned By Institutions | 13.60 % | |||
| Price To Earning | 10.80 X | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 11.51 X | |||
| Revenue | 559.04 M | |||
| Gross Profit | 489.67 M | |||
| EBITDA | (51.65 M) | |||
| Net Income | (69.84 M) | |||
| Cash And Equivalents | 458.1 M | |||
| Cash Per Share | 14.52 X | |||
| Total Debt | 42.5 M | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 4.49 X | |||
| Book Value Per Share | 23.35 X | |||
| Cash Flow From Operations | (20.51 M) | |||
| Earnings Per Share | (2.22) X | |||
| Number Of Employees | 1.16 K | |||
| Beta | 1.65 | |||
| Market Capitalization | 6.44 B | |||
| Total Asset | 453 M | |||
| Retained Earnings | (178 M) | |||
| Working Capital | 370 M | |||
| Current Asset | 405 M | |||
| Current Liabilities | 35 M | |||
| Z Score | 91.6 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in GWPRF OTC Stock
If you are still planning to invest in GW Pharmaceuticals Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GW Pharmaceuticals' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |